A Randomized, Open-label, Multiple Dosing, 2-way Crossover Study to Evaluate the Effect of Lobeglitazoneon Pharmacokinetics of Sitagliptin in Healthy Male Volunteers
Latest Information Update: 07 May 2020
At a glance
- Drugs Lobeglitazone (Primary) ; Lobeglitazone/sitagliptin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 30 Apr 2020 Results published in the Clinical Therapeutics
- 20 Jul 2016 New trial record